AMAT
40
-3
TJX
42
-9
NSC
47
-3
KMI
69
4
GOOG
55
-4
SLG
62
3
JNJ
42
-2
CA
13
3
HPE
38
-15
MRK
25
2
RCL
79
2
ADP
65
4
JPM
57
-5
HPQ
52
3
CI
38
-14
ROK
38
-14
DNB
66
2
AIZ
47
-2
PRGO
39
-4
PSA
51
5
AMAT
40
-3
TJX
42
-9
NSC
47
-3
KMI
69
4
GOOG
55
-4
SLG
62
3
JNJ
42
-2
CA
13
3
HPE
38
-15
MRK
25
2
RCL
79
2
ADP
65
4
JPM
57
-5
HPQ
52
3
CI
38
-14
ROK
38
-14
DNB
66
2
AIZ
47
-2
PRGO
39
-4
PSA
51
5
Financhill
Back

Nuveen S&P 500 Dynamic Overwrite Fund Vs. Viking Therapeutics Industry Stock Comparison

Sell
50

SPXX
Nuveen S&P 500 Dynamic Overwrite Fund

Last Price:
16.76
Seasonality Move:
1.84%
Sell
45

VKTX
Viking Therapeutics

Last Price:
64.63
Seasonality Move:
38.04%
Sell
50
Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is a Sell

Is Nuveen S&P 500 Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen S&P 500 Dynamic Overwrite Fund [SPXX] share price is $16.61. The Score for SPXX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SPXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPXX Stock Price Chart

What is Nuveen S&P 500 Dynamic Overwrite Fund's stock price today?

  • The Nuveen S&P 500 Dynamic Overwrite Fund share price today is $16.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPXX is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $63.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

SPXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 42.56 Sell
Chaikin Money Flow: -16354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.64 - 16.88) Sell
Bollinger Bands (100): (16.12 - 16.76) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 44.37 Sell
Chaikin Money Flow: -27799915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.04 - 71.46) Sell
Bollinger Bands (100): (52.9 - 66.58) Buy

SPXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.78 Sell
20-day SMA: 16.8 Sell
50-day SMA: 16.65 Sell
200-day SMA: 15.97 Buy
8-day EMA: 16.74 Sell
20-day EMA: 16.76 Sell
50-day EMA: 16.63 Sell
200-day EMA: 16.09 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.43 Sell
20-day SMA: 67.48 Sell
50-day SMA: 64.43 Sell
200-day SMA: 59.82 Buy
8-day EMA: 69.69 Sell
20-day EMA: 68.14 Sell
50-day EMA: 65.07 Sell
200-day EMA: 55.33 Buy

Nuveen S&P 500 Dynamic Overwrite Fund Earnings Growth & SPXX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

Nuveen S&P 500 Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):